12 Hrs
Source:
الاقتصادية
_1777294237270_124456903.png&w=64&q=75){kind=small}
Vaccine to produce 50M doses yearly in Saudi Arabia
A Saudi company specializing in vaccine manufacturing plans to begin production of its first vaccine by the end of 2027. The vaccine will be a seasonal influenza shot based on cell technology, with an annual production capacity of between 30 and 50 million doses. The factory aims to locally produce 80% of the vaccines needed in Saudi Arabia and intends to cover the local market before expanding for export, which could reach up to 25%. The project is the largest vaccine manufacturing facility in the Middle East and is characterized by employing more than 60% of Saudi professionals. It is part of the Kingdom’s strategy to strengthen the healthcare sector and reduce dependency on imports.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)